Cure Genetics
PrivateLast Round
Series B
Jan 5, 2022
Total Funding Raised
$79.2M
Company Overview
Cure Genetics is a biotechnology company that develops cell and gene therapies for solid tumors and genetic diseases using its proprietary AIMS CAR-NKT and VELP AAV platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cure Genetics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cure Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 5, 2022 | ||||
| Series A | Aug 6, 2018 | ||||
| Angel | Jan 1, 2017 |
Key People
Founding team and executive leadership
Cure Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series B |
| Blue Ocean Capital Group | Series B |
| Advantech Capital | Series B |
| Qiming Venture Partners | Series B, Series A |
Cure Genetics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cure Genetics's valuation, stock price, and market status.